EFORT: Autologous blood and saline injections similar for chronic patellar tendinopathy .
Double-blind randomised controlled trial: Injection of autologous blood for chronic patella tendinopathy
Twenty-two patients with chronic patellar tendinopathy were randomized to receive either an autologous blood injection (ABI) or saline injection to the patellar tendon. Participants were followed-up for 12 months thereafter using the McGill Pain Questionnaire and Victorian Institute of Sport Assessment (VISA) scale. Both the ABI group and saline group demonstrated significant improvement in both outcome measures of the follow-up period, although no significant differences were observed between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
